×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CODX – co-diagnostics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CODX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/11
08:09 am
codx
Co-Diagnostics, Inc. (NASDAQ: CODX) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $1.50 price target on the stock.
Medium
Report
Co-Diagnostics, Inc. (NASDAQ: CODX) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $1.50 price target on the stock.
11/10
07:47 am
codx
Co-Diagnostics Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Low
Report
Co-Diagnostics Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
11/8
10:19 am
codx
Co-Diagnostics Inc (CODX) Q3 2024 Earnings Call Highlights: Navigating Revenue Decline and ... [Yahoo! Finance]
Medium
Report
Co-Diagnostics Inc (CODX) Q3 2024 Earnings Call Highlights: Navigating Revenue Decline and ... [Yahoo! Finance]
11/7
06:40 pm
codx
Co-Diagnostics, Inc. (CODX) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]
Medium
Report
Co-Diagnostics, Inc. (CODX) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]
11/7
04:01 pm
codx
Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results
Low
Report
Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results
11/5
09:30 am
codx
Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in Düsseldorf, Germany on Nov 11-14, 2024
Low
Report
Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in Düsseldorf, Germany on Nov 11-14, 2024
10/25
04:01 pm
codx
Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast
Low
Report
Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast
10/21
09:30 am
codx
Co-Diagnostics, Inc. to Host Booth at Medlab Africa in Cape Town on Oct 22-24, 2024
Low
Report
Co-Diagnostics, Inc. to Host Booth at Medlab Africa in Cape Town on Oct 22-24, 2024
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/8
04:18 pm
codx
Form 8-K/A Co-Diagnostics, Inc. For: Aug 29
Medium
Report
Form 8-K/A Co-Diagnostics, Inc. For: Aug 29
11/7
04:07 pm
codx
Form 10-Q Co-Diagnostics, Inc. For: Sep 30
Low
Report
Form 10-Q Co-Diagnostics, Inc. For: Sep 30
11/7
04:02 pm
codx
Form 8-K Co-Diagnostics, Inc. For: Nov 07
Low
Report
Form 8-K Co-Diagnostics, Inc. For: Nov 07
10/18
04:31 pm
codx
Form 424B5 Co-Diagnostics, Inc.
Low
Report
Form 424B5 Co-Diagnostics, Inc.
8/30
04:31 pm
codx
Form 8-K Co-Diagnostics, Inc. For: Aug 29
Medium
Report
Form 8-K Co-Diagnostics, Inc. For: Aug 29
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/10
Co-Diagnostics down 39% on proliferation of COVID-19 competitors [Seeking Alpha]
89.0%
1/23 Co-Diagnostics, Inc. Designs Test for New Coronavirus Using CoPrimer™ Platform 79.6%
1/27 Vaccine, diagnostics stocks rise again on spreading coronavirus [MarketWatch] 38.1%
2/28 Form 424B5 Co-Diagnostics, Inc. 35.0%
4/16 Co-Diagnostics, Inc. COVID-19 Test Technology Validated for Use on Saliva Samples 30.6%
2/10 Co-Diagnostics, Inc. Announces Sales of New Coronavirus Test 28.2%
7/18 Co-Diagnostics Inc CoPrimers Provide High-Performance Detection of Cancer Mutations in Liquid Biopsy Samples 26.4%
2/6 Co-Diagnostics, Inc. Announces Launch of Test for New Coronavirus 24.2%
2/24 Co-Diagnostics, Inc. Receives CE Mark for Novel Coronavirus Test 20.2%
1/31 Coronavirus update: 213 dead, more countries recommending against China travel [MarketWatch] 19.4%
1/23 Co-Diagnostics, Inc. Designs Test for New Coronavirus Using CoPrimer™ Platform 79.6%
1/27 Vaccine, diagnostics stocks rise again on spreading coronavirus [MarketWatch] 38.1%
2/28 Form 424B5 Co-Diagnostics, Inc. 35.0%
4/16 Co-Diagnostics, Inc. COVID-19 Test Technology Validated for Use on Saliva Samples 30.6%
2/10 Co-Diagnostics, Inc. Announces Sales of New Coronavirus Test 28.2%
7/18 Co-Diagnostics Inc CoPrimers Provide High-Performance Detection of Cancer Mutations in Liquid Biopsy Samples 26.4%
2/6 Co-Diagnostics, Inc. Announces Launch of Test for New Coronavirus 24.2%
2/24 Co-Diagnostics, Inc. Receives CE Mark for Novel Coronavirus Test 20.2%
1/31 Coronavirus update: 213 dead, more countries recommending against China travel [MarketWatch] 19.4%
TOP News Decliners
2/28
Why Acquisition & Coordination of First Responders Data On COVID-19 Becoming Critically Essential
-34.3%
3/9 Co-Diagnostics Inc (NASDAQ: CODX) had its price target raised by analysts at HC Wainwright from $4.00 to $20.00. They now have a "buy" rating on the stock. -28.8%
3/12 Global Response to the COVID-19 Outbreak Intensifies -25.6%
1/27 Form 424B5 Co-Diagnostics, Inc. -23.6%
2/10 Co-Diagnostics up 36% on coronavirus test sales [Seeking Alpha] -19.7%
1/31 Coronavirus update: Trump declares coronavirus a public health emergency, U.S. citizens returning from Hubei Province to be quarantined [MarketWatch] -18.5%
3/2 Co-Diagnostics CEO on FDA's coronavirus policy changes [Yahoo! Finance News] -18.4%
3/3 Faulty COVID-19 Test Kits Tilt Scales in Coronavirus's Favor [The Motley Fool] -13.7%
3/17 Co-Diagnostics says new FDA policy to help expand use of COVID-19 test [Reuters (UK)] -13.5%
2/18 Co-Diagnostics (NASDAQ:CODX) Helping to Mitigate Global Economic Risk -12.8%
3/9 Co-Diagnostics Inc (NASDAQ: CODX) had its price target raised by analysts at HC Wainwright from $4.00 to $20.00. They now have a "buy" rating on the stock. -28.8%
3/12 Global Response to the COVID-19 Outbreak Intensifies -25.6%
1/27 Form 424B5 Co-Diagnostics, Inc. -23.6%
2/10 Co-Diagnostics up 36% on coronavirus test sales [Seeking Alpha] -19.7%
1/31 Coronavirus update: Trump declares coronavirus a public health emergency, U.S. citizens returning from Hubei Province to be quarantined [MarketWatch] -18.5%
3/2 Co-Diagnostics CEO on FDA's coronavirus policy changes [Yahoo! Finance News] -18.4%
3/3 Faulty COVID-19 Test Kits Tilt Scales in Coronavirus's Favor [The Motley Fool] -13.7%
3/17 Co-Diagnostics says new FDA policy to help expand use of COVID-19 test [Reuters (UK)] -13.5%
2/18 Co-Diagnostics (NASDAQ:CODX) Helping to Mitigate Global Economic Risk -12.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: